Duncan Williams Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.17M Sell
1,275
-24
-2% -$24.3K 0.33% 43
2025
Q4
$1.44M Buy
1,299
+916
+239% +$876K 0.36% 37
2025
Q3
$292K Buy
383
+55
+17% +$40.9K 0.08% 134
2025
Q2
$256K Buy
328
+75
+30% +$58.3K 0.08% 136
2025
Q1
$209K Buy
+253
New +$211K 0.08% 136
2024
Q4
Sell
-247
Closed -$219K 151
2024
Q3
$219K Buy
+247
New +$222K 0.12% 117

Other funds holding LLY

Duncan Williams Asset Management's LLY Position: Q1 2026 in Review

Duncan Williams Asset Management reduced its Eli Lilly (LLY) stake by 1.8% in Q1 2026, selling an estimated $24.3K and leaving 1,275 shares worth $1.17M. The position accounts for 0.33% of the portfolio, ranked #43.

Duncan Williams Asset Management first reported a position in LLY in Q3 2024 and has held it in 6 quarters since. The position peaked at $1.44M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Duncan Williams Asset Management held 1,275 shares of Eli Lilly worth $1.17M as of Q1 2026.
  • Duncan Williams Asset Management sold 24 Eli Lilly shares in Q1 2026, an estimated $24.3K.
  • Eli Lilly made up 0.33% of Duncan Williams Asset Management's portfolio in Q1 2026, its #43 holding.
  • Duncan Williams Asset Management first reported a position in Eli Lilly in Q3 2024 and has held it in 6 quarters since.
  • Duncan Williams Asset Management's Eli Lilly position peaked at $1.44M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Duncan Williams Asset Management's 13F filing for Q1 2026, filed 5 May 2026.